ライブセルイメージング市場規模、シェア、成長分析、製品・サービス別、用途別、技術別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

ライブセルイメージングの世界市場規模は、2022年に23億米ドルで、予測期間（2024-2031年）のCAGRは8.2%で、2023年の24億9,000万米ドルから2031年には46億7,000万米ドルに上昇すると予測されています。

ライブセルイメージング市場は、イメージング技術への投資増加や細胞研究開発需要の急増により、今後数年で大きく成長する見込みです。特に、腫瘍学研究におけるライブセルイメージングの活用が注目されており、幹細胞研究に向けられた多額の資金により、この分野の需要がさらに高まることが予想されます。創薬や薬剤開発における世界の活動が拡大し、政府からの資金援助や細胞治療への応用が増加するにつれて、ライブセルイメージングの需要もそれに応じて増加すると予想されます。さらに、人工知能と機械学習の統合は、調査期間中およびその後も市場シェアを獲得し、イノベーションを目指すライブセルイメージング企業の間で重要な動向として浮上しています。しかし、この市場は、標準化の欠如、運用コストの高さ、運用に伴う複雑さなど、かなりの課題に直面しており、長期的な発展の妨げになる可能性があります。全体として、ライブセルイメージング市場は、技術の進歩やヘルスケアにおけるセルラーアプリケーションへの注目の高まりに後押しされた機会を提供する一方で、現在進行中の業界の課題により、その可能性を完全に実現するには戦略的なナビゲーションが必要となります。

目次

イントロダクション

• 調査の目的
• 定義
• 市場範囲

調査手法

• 情報調達
• 二次データソースと一次データソース
• 市場規模予測
• 市場の想定と制限

エグゼクティブサマリー

• 市場概要見通し
• 供給需要動向分析
• セグメント別機会分析

市場力学と見通し

• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
• ポーターの分析

主な市場の考察

• 主な成功要因
• 競合の程度
• 主な投資機会
• 市場のエコシステム
• バリューチェーン分析
• 特許分析
• 技術分析
• 規制分析

ライブセルイメージング市場：製品・サービス別

• 市場概要
• 機器
  • 顕微鏡
  • スタンドアロンシステム
  • 細胞分析装置
  • アクセサリー
• 消耗品
  • 試薬
  • アッセイキット
  • メディア
  • その他の消耗品
• ソフトウェア
• サービス

ライブセルイメージング市場：用途別

• 市場概要
• 細胞生物学
• 発生生物学
• 幹細胞と創薬
• その他

ライブセルイメージング市場：技術別

• 市場概要
• タイムラプス顕微鏡
• 光退色後の蛍光回復（FRAP）
• 蛍光共鳴エネルギー移動（FRET）
• ハイコンテントスクリーニング（HCS）
• その他

ライブセルイメージング市場：エンドユーザー別

• 市場概要
• 製薬・バイオテクノロジー企業
• 学術調査機関
• 契約調査機関

ライブセルイメージング市場：地域別

• 市場概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ（MEA）
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ地域

競合情勢

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場における最近の活動
• 主要企業の市場シェア（2023年）

主要企業プロファイル

• Thermo Fisher Scientific
• Danaher Corporation
• PerkinElmer, Inc.
• Carl Zeiss AG
• Nikon Corporation
• Olympus Corporation
• Bruker Corporation
• GE HealthCare
• Becton, Dickinson & Company
• Sartorius AG
• BioTek Instruments（Agilent）
• CytoSMART Technologies
• Oxford Instruments Andor Ltd
• Live Cell Imaging, Inc.
• Olympus Life Science
• Tecan Group
• Cytena GmbH（BICO）
• Merck KGaA

Global Live Cell Imaging Market was valued at USD 2.3 Billion in 2022 and is expected to rise from USD 2.49 Billion in 2023 to USD 4.67 Billion by 2031, at a CAGR of 8.2% during the forecast period (2024-2031).

The live cell imaging market is poised for significant growth in the coming years, driven by increasing investments in imaging technologies and a surging demand for cell research and development. A particular focus on utilizing live cell imaging in oncology research and substantial funding directed towards stem cell research are expected to further enhance demand in this sector. As global activities in drug discovery and development expand, alongside supportive government funding and an uptick in cell therapy applications, the demand for live cell imaging is anticipated to rise correspondingly. Additionally, the integration of artificial intelligence and machine learning is emerging as a crucial trend among live cell imaging companies aiming to innovate and capture market share throughout the study period and beyond. However, the market does face considerable challenges, including a lack of standardization, high operational costs, and complexities associated with operations, which may hinder its long-term development. Overall, while the live cell imaging market presents exciting opportunities fueled by technological advancements and increased focus on cellular applications in healthcare, ongoing industry challenges will require strategic navigation to fully realize its potential.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Live Cell Imaging market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Live Cell Imaging Market Segmental Analysis

Global Live Cell Imaging Market is segmented by Product & Service, Application, Technology, End User and Region. Based on Product & Service, the market is segmented into Instruments (Microscopes, Standalone Systems, Cell Analyzers, Accessories), Consumables (Reagents, Assay Kits, Media, Other Consumables), Software, Services. Based on Application, the market is segmented into Cell Biology, Developmental Biology, Stem Cell & Drug Discovery, and Others. Based on Technology, the market is segmented into Time lapse Microscopy, Fluorescence recovery after photobleaching (FRAP), Fluorescence resonance energy transfer (FRET), High content screening (HCS), and Others. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Contract Research Organizations. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Live Cell Imaging Market

The surging focus of healthcare researchers on unlocking the intricate functionalities of cells is a significant market driver for the Global Live Cell Imaging market. As researchers aim to delve deeper into cellular behaviors, the demand for advanced cell-based technologies and products, particularly live cell imaging solutions, has escalated dramatically. This need is further amplified by the increasing recognition of the critical role that real-time observation of live cells plays in enhancing drug development, toxicology studies, and disease research. As innovation in imaging technologies progresses, the future landscape is set for robust growth, firmly establishing live cell imaging as an essential tool in cellular research.

Restraints in the Global Live Cell Imaging Market

One significant market restraint for the Global Live Cell Imaging market is the high cost associated with the development and procurement of advanced live cell imaging equipment and products. The intricate and sophisticated technologies involved in this field translate into substantial expenses for both the equipment and the consumables required for their operation. Consequently, research institutions operating under constrained budgets may find it challenging to invest in such high-end imaging solutions. This financial limitation can hinder the widespread adoption of live cell imaging techniques, ultimately restricting innovation and advancements within the research community and slowing overall market growth.

Market Trends of the Global Live Cell Imaging Market

The Global Live Cell Imaging market is witnessing a notable trend towards the adoption of advanced imaging technologies, particularly 3D and 4D imaging. As researchers seek deeper insights into cellular dynamics and interactions, the integration of these sophisticated imaging modalities is expected to significantly enhance the scope of live cell applications. This shift not only improves understanding of cellular structures but also facilitates real-time monitoring of biological processes. Consequently, companies in the live cell imaging sector are poised to leverage these advancements, driving innovation and expanding market potential as they cater to the evolving demands of the life sciences and biotechnology fields.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Value Chain Analysis
• Patent Analysis
• Technology Analysis
• Regulatory Analysis

Live Cell Imaging Market, By Product & Service

• Market Overview
• Instruments
  • Microscopes
  • Standalone Systems
  • Cell Analyzers
  • Accessories
• Consumables
  • Reagents
  • Assay Kits
  • Media
  • Other Consumables
• Software
• Services

Live Cell Imaging Market, By Application

• Market Overview
• Cell Biology
• Developmental Biology
• Stem Cell & Drug Discovery
• Others

Live Cell Imaging Market, By Technology

• Market Overview
• Time lapse Microscopy
• Fluorescence recovery after photobleaching (FRAP)
• Fluorescence resonance energy transfer (FRET)
• High content screening (HCS)
• Others

Live Cell Imaging Market, By End User

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Contract Research Organizations

Live Cell Imaging Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Carl Zeiss AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nikon Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE HealthCare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson & Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioTek Instruments (Agilent)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CytoSMART Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Instruments Andor Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Live Cell Imaging, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Life Science
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tecan Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytena GmbH (BICO)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments